Smurfit Westrock Q3 2026 earnings fall to $222M
Freight and energy costs rose as earnings and operating cash flow declined; the Chilean acquisition is expected to close in first-half 2027, subject to approvals.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Smurfit Westrock plc (SW) reported third-quarter 2026 net sales of $8.161 billion versus $8.003 billion a year earlier; net income attributable to common shareholders was $222 million versus $246 million. The company attributed the sales increase primarily to higher selling-price mix and volumes. Cost of goods sold rose to $6.721 billion from $6.434 billion, including higher freight and energy costs. Operating profit was $487 million versus $526 million, and diluted earnings per share were $0.42 versus $0.47.
For the first nine months of 2026, net sales were $23.904 billion versus $23.599 billion, while net income attributable to common shareholders was $376 million versus $602 million. Net cash provided by operating activities was $1.843 billion versus $2.197 billion; capital expenditures totaled $1.603 billion, and cash dividends paid were $712 million. The company agreed to acquire the Chilean Containerboard and Corrugated business of Empresas CMPC S.A. for $420 million, with closing expected in the first half of 2027, subject to customary closing conditions, including regulatory approvals. The board approved a quarterly dividend of $0.4523 per ordinary share, payable December 10, 2026, to shareholders of record November 13, 2026.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Moderate pointQ3 common-shareholder net income was $222 million, versus $246 million.
- Moderate pointNine-month common-shareholder net income was $376 million, versus $602 million.
- Moderate pointNine-month operating cash flow was $1.843 billion, versus $2.197 billion.
Filing Explained
At September 30, 2026, total debt was $14,049 million, and the $4,500 million revolving facility had no amounts drawn.
This Form 10-Q reports that a court denied a motion to dismiss an antitrust class-action complaint against two Smurfit Westrock subsidiaries and other industry participants on
Separately, an arbitral award granted subsidiary Smurfit Holdings BV compensation exceeding
Key Figures
Key Terms
Adjusted EBITDA financial
accounts receivable monetization agreements financial
supplier finance programs financial
Variable Interest Entities financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were SW's third-quarter 2026 sales and earnings?
What drove SW's third-quarter 2026 sales change?
What is SW's next quarterly dividend and payment date?
AI-generated analysis. How Rhea-AI works. Not financial advice.
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
N/A | ||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
☒ | Accelerated filer | ☐ | |
Non-accelerated filer | ☐ | Smaller reporting company | |
Emerging growth company | |||
Page | ||
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | 3 | |
PART I | FINANCIAL INFORMATION | 5 |
Item 1. | Financial Statements | 5 |
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and September 30, 2025 | 5 | |
Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2026 and September 30, 2025 | 6 | |
Condensed Consolidated Balance Sheets as of September 30, 2026 and December 31, 2025 | 7 | |
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and September 30, 2025 | 8 | |
Condensed Consolidated Statements of Changes in Equity for the three and nine months ended September 30, 2026 and September 30, 2025 | 9 | |
Notes to Condensed Consolidated Financial Statements | 12 | |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 32 |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 44 |
Item 4. | Controls and Procedures | 44 |
PART II | OTHER INFORMATION | 46 |
Item 1. | Legal Proceedings | 46 |
Item 1A. | Risk Factors | 46 |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 46 |
Item 3. | Defaults Upon Senior Securities | 46 |
Item 4. | Mine Safety Disclosures | 46 |
Item 5. | Other Information | 46 |
Item 6. | Exhibits | 47 |
Signatures | 48 |
Three months ended September 30, | Nine months ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net sales | $ | $ | $ | $ | |||
Cost of goods sold | ( | ( | ( | ( | |||
Gross profit | |||||||
Selling, general and administrative expenses | ( | ( | ( | ( | |||
Impairment and restructuring costs | ( | ( | ( | ( | |||
Transaction and integration-related expenses associated with the Combination | ( | ( | ( | ||||
Operating profit | |||||||
Interest expense, net | ( | ( | ( | ( | |||
Pension and other postretirement non-service income, net | |||||||
Other expense, net | ( | ( | ( | ( | |||
Income before income taxes | |||||||
Income tax expense | ( | ( | ( | ( | |||
Net income | |||||||
Net loss attributable to noncontrolling interests | |||||||
Net income attributable to common shareholders | $ | $ | $ | $ | |||
Basic earnings per share attributable to common shareholders | $ | $ | $ | $ | |||
Diluted earnings per share attributable to common shareholders | $ | $ | $ | $ | |||
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||||||
Three months ended September 30, | Nine months ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net income | $ | $ | $ | $ | |||
Other comprehensive (loss) income, net of tax: | |||||||
Foreign currency translation (loss) gain | ( | ( | |||||
Defined benefit pension and other postretirement benefit plans | ( | ||||||
Net gain (loss) on cash flow hedges | ( | ||||||
Other comprehensive (loss) income, net of tax | ( | ( | |||||
Comprehensive income | |||||||
Comprehensive loss attributable to noncontrolling interests | |||||||
Comprehensive income attributable to common shareholders | $ | $ | $ | $ | |||
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||||||
September 30, 2026 | December 31, 2025 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents (amounts related to consolidated variable interest entities of $ $ | $ | $ | |
Accounts receivable, net (amounts related to consolidated variable interest entities of $ $ | |||
Inventories | |||
Other current assets | |||
Total current assets | |||
Property, plant and equipment, net | |||
Goodwill | |||
Intangibles, net | |||
Prepaid pension asset | |||
Other non-current assets (amounts related to consolidated variable interest entities of $ $ | |||
Total assets | $ | $ | |
Liabilities and Equity | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Accrued expenses | |||
Accrued compensation and benefits | |||
Current portion of debt | |||
Other current liabilities | |||
Total current liabilities | |||
Non-current debt due after one year (amounts related to consolidated variable interest entities of $ | |||
Deferred tax liabilities | |||
Pension liabilities and other postretirement benefits, net of current portion | |||
Other non-current liabilities (amounts related to consolidated variable interest entities of $ and $ | |||
Total liabilities | |||
Commitments and Contingencies (Note 14) | |||
Equity: | |||
Preferred stock, $ | |||
Common stock, $ shares outstanding at September 30, 2026 and December 31, 2025, respectively | |||
Treasury stock, at cost; December 31, 2025, respectively | ( | ( | |
Capital in excess of par value | |||
Accumulated other comprehensive loss | ( | ( | |
Retained earnings | |||
Total shareholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Nine months ended September 30, | |||
2026 | 2025 | ||
Operating activities: | |||
Net income | $ | $ | |
Adjustments to reconcile consolidated net income to net cash provided by operating activities: | |||
Depreciation, depletion and amortization | |||
Impairment of assets | |||
Cash surrender value increase in excess of premiums paid | ( | ( | |
Share-based compensation expense | |||
Deferred income tax benefit | ( | ( | |
Pension and other postretirement funding more than cost | ( | ( | |
Other | |||
Change in operating assets and liabilities, net of acquisitions and divestitures: | |||
Accounts receivable | ( | ( | |
Inventories | ( | ( | |
Other assets | ( | ||
Accounts payable | ( | ||
Income taxes | ( | ||
Accrued liabilities and other | |||
Net cash provided by operating activities | |||
Investing activities: | |||
Capital expenditures | ( | ( | |
Cash paid for purchase of businesses, net of cash acquired | ( | ( | |
Proceeds from corporate owned life insurance | |||
Proceeds from sale of property, plant and equipment | |||
Other | |||
Net cash used for investing activities | ( | ( | |
Financing activities: | |||
Additions to debt | |||
Repayments of debt | ( | ( | |
Debt issuance costs | ( | ( | |
Changes in commercial paper, net | ( | ||
Other debt additions (repayments), net | ( | ||
Repayments of finance lease liabilities | ( | ( | |
Proceeds from re-issuance of shares from treasury stock | |||
Tax paid in connection with shares withheld from employees | ( | ( | |
Cash dividends paid to shareholders | ( | ( | |
Other | |||
Net cash used for financing activities | ( | ( | |
Effect of exchange rate changes on cash and cash equivalents | ( | ||
Decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at beginning of period | |||
Cash and cash equivalents at end of period | $ | $ | |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interests | Total | |
Balance at June 30, 2026 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | ( | |||
Other comprehensive loss, net of tax | — | — | — | — | — | ( | ( | — | ( |
Share-based compensation | — | — | — | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | — | — | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at September 30, 2026 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interests | Total | |
Balance at June 30, 2025 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | ( | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at September 30, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interests | Total | |
Balance at December 31, 2025 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | ( | |||
Other comprehensive loss, net of tax | — | — | — | — | — | ( | ( | — | ( |
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust, net of tax paid in connection with shares withheld from employees | — | — | ( | ( | — | ( | — | ( | |
Re-issuance of shares by Smurfit Kappa Employee Trust | — | — | — | — | — | ||||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of shares held in treasury stock by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | — | ||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at September 30, 2026 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interests | Total | |
Balance at December 31, 2024 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | ( | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | — | ||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of shares held in treasury stock by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | — | ||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at September 30, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
Three months ended September 30, 2026 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | |||||||
Income before income taxes | $ |
Three months ended September 30, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Nine months ended September 30, 2026 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Nine months ended September 30, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Nine months ended September 30, | |||
2026 | 2025 | ||
Capital expenditures: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total per reportable segments | $ | $ | |
Corporate | |||
Total capital expenditures | $ | $ | |
Three months ended September 30, 2026 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Three months ended September 30, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Nine months ended September 30, 2026 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Nine months ended September 30, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Impairment charges | $ | $ | $ | $ | |||
Restructuring costs | |||||||
Impairment and restructuring costs | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Impairment of property, plant and equipment | $ | $ | $ | $ | |||
Impairment of other assets | |||||||
Total impairment charges | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
North America | $ | $ | $ | $ | |||
Europe, MEA and APAC | |||||||
LATAM | |||||||
Total impairment charges recognized for property, plant and equipment | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
North America | $ | $ | $ | $ | |||
Europe, MEA and APAC | |||||||
LATAM | ( | ||||||
Total restructuring costs | $ | $ | $ | $ | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Severance charges | $ | $ | $ | $ | |||
Other costs | |||||||
Total restructuring costs | $ | $ | $ | $ | |||
September 30, | December 31, | ||
2026 | 2025 | ||
Gross accounts receivable | $ | $ | |
Less: Allowances | ( | ( | |
Accounts receivable | $ | $ |
September 30, | December 31, | ||
2026 | 2025 | ||
Finished goods | $ | $ | |
Work-in-progress | |||
Raw materials | |||
Consumables and spare parts | |||
Inventories | $ | $ |
September 30, | December 31, | ||
2026 | 2025 | ||
Land and buildings | $ | $ | |
Plant and equipment | |||
Construction-in-progress | |||
Finance lease right-of-use assets | |||
Property, plant and equipment at cost, excluding forestlands | |||
Less: Accumulated depreciation and impairment | ( | ( | |
Property, plant and equipment, net, excluding forestlands | |||
Forestlands, net of depletion | |||
Property, plant and equipment, net | $ | $ |
Three months ended September 30, | Nine months ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Interest expense | $( | $( | $( | $( | |||
Interest income | |||||||
Interest expense, net | $( | $( | $( | $( | |||
September 30, 2026 | December 31, 2025 | ||||||
Book Value | Fair Value | Book Value | Fair Value | ||||
Debt with fixed interest rates | $ | $ | $ | $ | |||
Nine months ended September 30, | |||
2026 | 2025 | ||
Receivable from financial institutions at January 1 | $ | $ | |
Receivables sold to the financial institutions and derecognized | ( | ( | |
Receivables collected by financial institutions | |||
Cash payments to financial institutions | ( | ( | |
Receivable from financial institutions at September 30 | $ | $ | |
September 30, | December 31, | ||
2026 | 2025 | ||
$ | $ | $ | |
$ | |||
$ | |||
€ | |||
€ | |||
€ | |||
$ | |||
$ | |||
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
€ | |||
$ | |||
€ | |||
$ | |||
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
$ | |||
Commercial paper | |||
Vendor financing and commercial card programs | |||
Farm credit facility | |||
Other bank loans | |||
Finance lease obligations | |||
Total debt, excluding fair value adjustments, bond discounts and debt issuance costs | |||
Unamortized fair value adjustments, bond discounts and debt issuance costs | ( | ( | |
Total debt | |||
Less: Current portion of debt | ( | ( | |
Non-current debt due after one year | $ | $ |
Defined Benefit Pension Plans | |||||||||||||||
U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | ||||||||||||
Three months ended September 30, | Nine months ended September 30, | ||||||||||||||
2026 | 2025 | 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | ||||||||
Service cost | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Interest cost | |||||||||||||||
Expected return on assets | ( | ( | ( | ( | ( | ( | ( | ( | |||||||
Amortization of: | |||||||||||||||
Net actuarial loss | |||||||||||||||
Prior service credit | ( | ||||||||||||||
Curtailment gain | ( | ||||||||||||||
Settlement gain | ( | ||||||||||||||
Net periodic benefit (income) cost | $( | $( | $ | $ | $( | $( | $ | $ | |||||||
Three months ended September | Nine months ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Numerator: | |||||||
Net income attributable to common shareholders | $ | $ | $ | $ | |||
Denominator: | |||||||
Basic weighted average shares outstanding | |||||||
Effect of dilutive share options | |||||||
Diluted weighted average shares outstanding | |||||||
Basic earnings per share attributable to common shareholders | $ | $ | $ | $ | |||
Diluted earnings per share attributable to common shareholders | $ | $ | $ | $ | |||
September 30, | December 31, | ||
2026 | 2025 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Accounts receivable | |||
Inventories | |||
Other current assets | |||
Non-current assets: | |||
Property, plant and equipment, net | |||
Other non-current assets | |||
Total assets | $ | $ | |
Liabilities | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Current portion of debt | |||
Other current liabilities | |||
Non-current liabilities: | |||
Non-current debt due after one year | |||
Other non-current liabilities | |||
Total liabilities | $ | $ |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Other Postretirement Benefit Plans | Other Adjustments(1) | Total(2) | |
Balance at June 30, 2025 | $ | $ | $ | $( | $ |
Other comprehensive income | ( | ( | ( | ( | |
Balance at September 30, 2025 | $ | $ | $ | $( | $ |
Balance at June 30, 2026 | $ | $ | $ | $( | $ |
Other comprehensive loss (income) | ( | ||||
Balance at September 30, 2026 | $ | $ | $ | $( | $ |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Other Postretirement Benefit Plans | Other Adjustments(1) | Total(2) | |
Balance at December 31, 2024 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | |||
Balance at September 30, 2025 | $ | $ | $ | $( | $ |
Balance at December 31, 2025 | $ | $ | $ | $( | $ |
Other comprehensive loss (income) | ( | ||||
Balance at September 30, 2026 | $ | $ | $ | $( | $ |
Three months ended September 30, | |||||||
2026 | 2025 | ||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | ||
Foreign currency translation (loss) gain | $( | $ | $( | $ | $ | $ | |
Defined benefit pension and other postretirement benefit plans: | |||||||
Amortization and settlement recognition of net actuarial loss | ( | ( | |||||
Foreign currency gain - pensions | |||||||
Changes in fair value of cash flow hedges | |||||||
Consolidated other comprehensive (loss) income | ( | ( | ( | ( | |||
Other comprehensive income attributable to noncontrolling interests | |||||||
Other comprehensive (loss) income attributable to common shareholders | $( | $( | $( | $ | $( | $ | |
Nine months ended September 30, | |||||||
2026 | 2025 | ||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | ||
Foreign currency translation (loss) gain | $( | $ | $( | $ | $ | $ | |
Defined benefit pension and other postretirement benefit plans: | |||||||
Net actuarial gain (loss) arising during the period | ( | ( | ( | ||||
Amortization and settlement recognition of net actuarial loss | ( | ( | |||||
Prior service cost arising during period | ( | ( | |||||
Amortization of prior service credit | ( | ( | |||||
Foreign currency gain (loss) - pensions | ( | ( | |||||
Changes in fair value of cash flow hedges | ( | ( | |||||
Consolidated other comprehensive (loss) income | ( | ( | ( | ||||
Other comprehensive income attributable to noncontrolling interests | |||||||
Other comprehensive (loss) income attributable to common shareholders | $( | $( | $( | $ | $ | $ | |
Three months ended September 30, | Nine months ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net sales | $8,161 | $8,003 | $23,904 | $23,599 | |||
Cost of goods sold | (6,721) | (6,434) | (19,797) | (18,938) | |||
Gross profit | 1,440 | 1,569 | 4,107 | 4,661 | |||
Selling, general and administrative expenses | (927) | (963) | (2,858) | (2,899) | |||
Impairment and restructuring costs | (26) | (65) | (199) | (360) | |||
Transaction and integration-related expenses associated with the Combination | — | (15) | (1) | (72) | |||
Operating profit | 487 | 526 | 1,049 | 1,330 | |||
Interest expense, net | (174) | (177) | (519) | (526) | |||
Pension and other postretirement non-service income, net | 8 | 8 | 26 | 24 | |||
Other expense, net | (7) | (21) | (30) | (44) | |||
Income before income taxes | 314 | 336 | 526 | 784 | |||
Income tax expense | (95) | (91) | (156) | (183) | |||
Net income | 219 | 245 | 370 | 601 | |||
Net loss attributable to noncontrolling interests | 3 | 1 | 6 | 1 | |||
Net income attributable to common shareholders | $222 | $246 | $376 | $602 | |||
Three months ended September 30, | Nine months ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net sales (aggregate):(1) | |||||||
North America | $4,859 | $4,721 | $14,104 | $14,145 | |||
Europe, MEA and APAC | 2,836 | 2,831 | 8,433 | 8,191 | |||
LATAM | 588 | 545 | 1,687 | 1,576 | |||
Segment Adjusted EBITDA: | |||||||
North America | $760 | $810 | $2,061 | $2,347 | |||
Europe, MEA and APAC | 379 | 419 | 1,180 | 1,180 | |||
LATAM | 126 | 116 | 359 | 354 | |||
Nine months ended September 30, | |||
2026 | 2025 | ||
Net cash provided by operating activities | $1,843 | $2,197 | |
Net cash used for investing activities | $(1,554) | $(1,564) | |
Net cash used for financing activities | $(440) | $(674) | |
Three months ended September 30, | Nine months ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net income | $219 | $245 | $370 | $601 | |||
Income tax expense | 95 | 91 | 156 | 183 | |||
Depreciation, depletion and amortization | 678 | 659 | 2,084 | 1,875 | |||
Impairment and restructuring costs | 26 | 65 | 199 | 360 | |||
Transaction and integration-related expenses associated with the Combination | — | 15 | 1 | 72 | |||
Interest expense, net | 174 | 177 | 519 | 526 | |||
Pension and other postretirement non-service income, net | (8) | (8) | (26) | (24) | |||
Share-based compensation expense | 21 | 35 | 76 | 114 | |||
Other expense, net | 7 | 21 | 30 | 44 | |||
Other adjustments | (7) | 2 | 12 | 16 | |||
Adjusted EBITDA | $1,205 | $1,302 | $3,421 | $3,767 | |||
SUMMARIZED STATEMENT OF OPERATIONS | Nine months ended September 30, |
2026 | |
Net sales to unrelated parties | $1,116 |
Net sales to Non-Obligor Subsidiaries | 965 |
Gross profit | 587 |
Interest expense, net with unrelated parties | (457) |
Interest expense, net with Non-Obligor Subsidiaries | (241) |
Net income and net income attributable to the Obligor Group | 3,156 |
SUMMARIZED BALANCE SHEETS | September 30, 2026 | December 31, 2025 | |
ASSETS | |||
Current amounts due from Non-Obligor Subsidiaries | $4,741 | $4,571 | |
Other current assets | 894 | 1,207 | |
Total current assets | $5,635 | $5,778 | |
Non-current amounts due from Non-Obligor Subsidiaries | $3,271 | $3,355 | |
Other non-current assets | 940 | 918 | |
Total non-current assets | $4,211 | $4,273 | |
LIABILITIES | |||
Current amounts due to Non-Obligor Subsidiaries | $7,476 | $9,130 | |
Other current liabilities | 962 | 482 | |
Total current liabilities | $8,438 | $9,612 | |
Non-current amounts due to Non-Obligor Subsidiaries | $7,134 | $7,447 | |
Other non-current liabilities | 11,625 | 11,823 | |
Total non-current liabilities | $18,759 | $19,270 |
Exhibit Number | Description of Exhibit | ||
3.1 | Amended Constitution of Smurfit Westrock plc (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed on July 8, 2024). | ||
10.1†+ | Third Amendment to Purchasing and Servicing of Receivables, dated as of September 15, 2026, among Smurfit Westrock plc, various WestRock Company subsidiaries, and Coöperatieve Rabobank, U.A. | ||
22 | List of Guarantor Subsidiaries and Issuers of Guaranteed Securities (incorporated by reference to Exhibit 22 of the Company’s Annual Report on Form 10-K filed on February 27, 2026). | ||
31.1† | Certification of the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
31.2† | Certification of the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
32†* | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.** | ||
101.SCH | Inline XBRL Taxonomy Extension Schema.** | ||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase.** | ||
101.DEF | Inline XBRL Taxonomy Extension Definition Document.** | ||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase.** | ||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase.** | ||
104 | Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
Smurfit Westrock plc | ||
Dated: November 4, 2026 | /s/ Anthony Smurfit | |
Name: | Anthony Smurfit | |
Title: | President & Chief Executive Officer | |
(Principal Executive Officer) | ||
Smurfit Westrock plc | ||
Dated: November 4, 2026 | /s/ Ken Bowles | |
Name: | Ken Bowles | |
Title: | Executive Vice President & Chief Financial Officer | |
(Principal Financial Officer) | ||